Cys-FAP targeting peptide for FXX489

Cat. No.: HY-P10945A: Ficha de datos Instrucciones de manejo
FAQs
Technical Support

Cys-FAP targeting peptide for FXX489 is the polypeptide part of Unlabeled FXX489 (HY-P10944). Unlabeled FXX489 is a fibroblast activation protein (FAP)-targeting ligand.

Para uso exclusivo en investigación. No vendemos a pacientes.

Síntesis de péptidos personalizados

Cys-FAP targeting peptide for FXX489 Estructura química

Tamaño		Stock
MOQ		Minimum order quantity
50 mg		Obtener un presupuesto
100 mg		Obtener un presupuesto
250 mg		Obtener un presupuesto
Other size		Obtener un presupuesto

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Other In-stock Forms of Cys-FAP targeting peptide for FXX489:

Cys-FAP targeting peptide for FXX489 TFA

Other Forms of Cys-FAP targeting peptide for FXX489:

FAP targeting peptide for FXX489 In-stock
Cys-FAP targeting peptide for FXX489 TFA In-stock

Recomendaciones destacadas

•Related Small Molecules:

•Related Proteins:

Ver todos los productos específicos de isoformas Radionuclide-Drug Conjugates (RDCs):

Ver todas las isoformas

RDC Peptide RDC Antibody RDC Bifunctional Chelator RDC Linker Other

Actividad biológica
Pureza y Documentación
Referencias
Revisión del cliente

Descripciòn	Cys-FAP targeting peptide for FXX489 is the polypeptide part of Unlabeled FXX489 (HY-P10944). Unlabeled FXX489 is a fibroblast activation protein (FAP)-targeting ligand^[1].
In Vitro	Cys-FAP targeting peptide for FXX489 can form Unlabeled FXX489, which can target fibroblast activation protein (FAP) and thus possesses pan-cancer inhibitory activity. After being labeled with 68Ga and 177Lu, Unlabeled FXX489 has good tumor retention and anti-tumor activity in various cancers^[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Cys-FAP targeting peptide for FXX489 Related Antibodies
Peso molecular	1449.67
Fòrmula	C₇₀H₉₆N₁₆O₁₆S
Envío	Room temperature in continental US; may vary elsewhere.
Almacenamiento	Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación	Ficha de datos (257 KB) Instrucciones de manejo (2659 KB)
Referencias	[1]. Ravit Geva, et al. Abstract CT112: Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of FXX489 ([177Lu]Lu-NNS309) in patients with pancreatic, lung, breast and colorectal cancers. Cancer Res (2025) 85 (8_Supplement_2): CT112.